Life Following Excision of Neuroendocrine Tumors

Recruiting Observational Study
Neuroendocrine (NE) Tumors Neuroendocrine Tumor GEP Grade 1-3
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
246 (estimated)
Sponsor
Sunnybrook Health Sciences Centre · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Neuroendocrine tumors (NETs), often seen as "chronic cancer" present a survival paradox with relatively prolonged patient survival despite active disease. Treatment strategies emphasize management over cure, integrating tumor control with quality of life (QOL) considerations. Surgery is a cornerstone of NET management but demands a careful balance between its potential benefits and the morbidity r…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age \>18 years old * Diagnosis of well-differentiated grade 1 to 3 NETs via histopathology (biopsy) or imaging (measurable tumor on CT or MRI with avidity on SSTR-PET scan). * Consents to surgery for resection of localized, loco-regional, or metastatic gastro-enteric (midgut) …
Contacts

Jessica Armah, MSc

416-480-6100

jessica.armah@sri.utoronto.ca

CONTACT